from:brown_mary_jo@lilly.com means BROWN_MARY_JO@LILLY.COM (brown_mary_jo@lilly.com).
-
15 Nov 2001
Board/Senior Management Retreat - June 2003
As we begin to work on our board/senior management retreat for 2003, we would like to test your interest in the possibility of holding the meeting in Shanghai during the …
-
14 Nov 2001
**PRESS RELEASE**Lilly Commences Tender Offers for Various Debt Securities
The attached news release went out via Business Wire at 8:03 a.m. today. - Tender Offer Release Nov 01.doc
-
5 Nov 2001
ISIS 3521 Release
We thought you might be interested in this ISIS press release regarding the compound we are developing with ISIS for the treatment of non-small cell lung cancer. - ISIS 3…
-
29 Oct 2001
**PRESS RELEASE**Lilly Receives Approvable Letter From FDA for Xigris
The attached news release crossed Business Wire at 8:16 a.m. today - Xigris Approvable Letter release.doc
-
25 Oct 2001
**PRESS RELEASE**Lilly Responds to the Nation's Bioterrorism Threat
The attached news release was sent out via Business Wire at approximately 4:00 p.m. today. - Bioterrorism release.doc
-
24 Oct 2001
***PRESS RELEASES***
The attached news releases were issued via Business Wire at 7:00 a.m. (Indpls time) today. - 2001 Investment Community Press Release.doc - bioprojet press release.doc
-
23 Oct 2001
**PRESS RELEASE**New Data Shows That Lilly Oncology's Anti-Cancer Agent
The attached press release was sent over Business Wire at 7:00 a.m. (ET) today. - Alimta-Pleural Mesothelioma release.doc
-
18 Oct 2001
**PRESS RELEASE** Applications For 2002-2003 Lilly Reintegration Scholarship Program Now Available
The attached press release was issued over Business Wire today at 11:28 a.m. Indy time. [IMAGE] - Reintegration Scholarships.doc
-
16 Oct 2001
Press Release
The attached press release was issued today over Business Wire at approximately 5:56 pm (EST) Indy time. We will keep you advised of developments. Alecia DeCoudreaux - FD…
-
4 Jun 2001
**PRESS RELEASE** Initiative to Accelerate Research Breakthroughs Enters 2nd Year
The attached press release was issued this morning over Business Wire at 9:00 AM ET. - Clinical Investigator Award Release.doc
-
1 Jun 2001
**PRESS RELEASE** Zyprexa Approved for Treatment of Schizophrenia in Japan
The attached press release was issued this morning over Business Wire at 8:50 AM EST. - Japan Zyprexa Approval PR 060101.doc
-
1 Jun 2001
***PRESS RELEASE*** In a New Phase III Study, CialisTM (IC351) 20 mg Improved Erections in 85 Percent of Men With Erectile Dysfunction, Regardless of Severity
The attached press release was issued over Business Wire this morning at 7:55 AM ET. - Cialis Phase III Duration FINAL 060101.doc
-
30 May 2001
CAFC Ruling on 2003 Prozac Patent
We learned today that the Court of Appeals for the Federal Circuit has modified its opinion of August 9, 2000 in which it found the 2003 Prozac patent invalid for double …
-
6 Dec 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, jterzuoli@ibjwhitehall.com, karen.n.horn@marshmc.com and 6 more
***PRESS RELEASE***Lilly Announces $48 Million Expansion of Research Facilities
The attached press release was issued at Noon today. (See attached file: Greenfield Expansion Release.doc) - Greenfield Expansion Release.doc
-
4 Dec 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 13 more
Transactions in Lilly Stock
This is a reminder of your ongoing obligation to report to the Securities and Exchange Commission ("SEC") transactions in Lilly stock. In light of the complexity of the r…
-
20 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 8 more
***PRESS RELEASE*** 82 Win Lilly Reintegration Scholarship
The attached press release was issued over PR Newswire at 12:00 p.m. this afternoon. (See attached file: Reintegration Scholarships-National.doc) - Reintegration Scholars…
-
16 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 8 more
**PRESS RELEASE**LEXICON GENETICS SUBLICENSES POSITIVE-NEGATIVE SELECTION AND ISOGENIC DNA TECHNOLOGIES TO ELI LILLY AND COMPANY
The attached press release below was issued by Lexicon at 7:00 am this morning. (See attached file: Lexicon Genetics Sublicense.doc) - Lexicon Genetics Sublicense.doc
-
15 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 8 more
**PRESS RELEASE**
The attached news release was sent over PRNewswire in the last 20 minutes. (See attached file: Prozac Pediatric Release - Approval.doc) - Prozac Pediatric Release - Appro…
-
14 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 14 more
Shareholder Letter re Presidential Candidates' Medicare Proposals
We have received several responses to Sidney's letter to shareholders, both positive and negative. A few shareholders indicated that copies of their response would be sen…
-
2 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 13 more
Transactions in Lilly Stock
This is a reminder of your ongoing obligation to report to the Securities and Exchange Commission ("SEC") transactions in Lilly stock. In light of the complexity of the r…
-
2 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 12 more
Letter to Shareholders
Attached for your information is the letter to shareholders that Sidney mentioned at the October board meeting. If you have any questions, please call me. Alecia DeCoudre…
-
1 Nov 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 9 more
**PRESS RELEASE**re; Evista Early Effects
The attached news release was sent over PRNewswire early this morning. (See attached file: Evista Early Effects Release.doc) - Evista Early Effects Release.doc
-
23 Oct 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 6 more
**PRESS RELEASE** Sanofi-Synth,labo purchases Eli Lilly's share of their US-based oncology joint venture and recovers full US rights to oxaliplatin
To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, kenneth.lay@enron.com, kseifert@kcc.com, prendergast@mayo.…
-
19 Oct 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 8 more
**PRESS RELEASE**3Q00 Sales and Earnings
The attached press release was sent over PRNewswire at 6:00 a.m. today. (See attached file: 3Q00 Sales and Earnings Release.doc) - 3Q00 Sales and Earnings Release.doc
-
19 Oct 2000
BROWN_MARY_JO@LILLY.COM to alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com and 8 more
**PRESS RELEASE ISSUED BY SEPRACOR**
The attached press release was issued by Sepracor at 6:00 a.m. today. (See attached file: Sepracor Release.doc) - Sepracor Release.doc